General discussion, page-15260

yes @MickeyMantle536 well trodden and a recurring point in the economic cycle confirmed by the big boys declaring they are on the hunt for transaction acquisition targets ....science meets long term value driver = long term revenue loss mitigation
IHL could not be better placed at this point in the cycle with the 'shelf' of drug candidates addressing global unmet need ....
great place to be a holder right now - multiple billions is a fair estimation in relative term to the sector